Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 184
Filter
1.
S Afr Med J ; 114(1b): e711, 2024 Feb 02.
Article in English | MEDLINE | ID: mdl-38525666

ABSTRACT

BACKGROUND: Over 30% of the world's population is anaemic, with a significant proportion of these being iron deficient. As iron deficiency (ID) anaemia in men and post-menopausal women is mostly caused by gastrointestinal blood loss or malabsorption, the initial evaluation of a patient with ID anaemia involves referral to a gastroenterologist. The current drive towards patient blood management in sub-Saharan Africa (SSA)prescribes that we regulate not only the use of blood transfusion but also the management of patients in whom the cause of iron loss or inadequate iron absorption is sought. Recommendations have been developed to: (i) aid clinicians in the evaluation of suspected gastrointestinal iron loss and iron malabsorption, and often a combination of these; (ii) improve clinical outcomes for patients with gastrointestinal causes of ID; (iii) provide current, evidence-based, context-specific recommendations for use in the management of ID; and (iv) conserve resources by ensuring rational utilisation of blood and blood products. METHOD: Development of the guidance document was facilitated by the Gastroenterology Foundation of Sub-Saharan Africa and the South African Gastroenterology Society. The consensus recommendations are based on a rigorous process involving 21 experts in gastroenterology and haematology in SSA. Following discussion of the scope and purpose of the guidance document among the experts, an initial review of the literature and existing guidelines was undertaken. Thereafter, draft recommendation statements were produced to fulfil the outlined purpose of the guidance document. These were reviewed in a round-table discussion and were subjected to two rounds of anonymised consensus voting by the full committee in an electronic Delphi exercise during 2022 using the online platform, Research Electronic Data Capture. Recommendations were modified by considering feedback from the previous round, and those reaching a consensus of over 80% were incorporated into the final document. Finally, 44 statements in the document were read and approved by all members of the working group. CONCLUSION: The recommendations incorporate six areas, namely: general recommendations and practice, Helicobacter pylori, coeliac disease, suspected small bowel bleeding, inflammatory bowel disease, and preoperative care. Implementation of the recommendations is aimed at various levels from individual practitioners to healthcare institutions, departments and regional, district, provincial and national platforms. It is intended that the recommendations spur the development of centre-specific guidelines and that they are integrated with the relevant patient blood management protocols. Integration of the recommendations is intended to promote optimal evaluation and management of patients with ID, regardless of the presence of anaemia.


Subject(s)
Anemia, Iron-Deficiency , Iron , Male , Humans , Female , South Africa , Iron/therapeutic use , Anemia, Iron-Deficiency/diagnosis , Anemia, Iron-Deficiency/therapy , Blood Transfusion
2.
Trop Anim Health Prod ; 56(2): 47, 2024 Jan 18.
Article in English | MEDLINE | ID: mdl-38233625

ABSTRACT

Very little information is available on the quality of wool produced by terminal crosses out of wool producing dam lines. This study was therefore undertaken to elucidate the wool quality traits of four crossbred lines relative to Merinos and Dohne Merinos, which served as dam lines. Each dam line was mated to rams of their own breed as well as to Dormer or Ile de France rams to create four crossbred lines, namely, Dohne x Dormer, Dohne x Ile de France, Merino x Dormer, and Merino x Ile de France, in addition to the purebred Dohne Merino and Merino lines. Four rams and four ewes from each of these lines were reared up to one year of age under optimal growth conditions and shorn at the end of that time. Fleeces were weighed and samples collected for analysis. Neither sex nor genotype influenced clean fleece weight or clean yield percentage, but fibre diameter differed between genotypes. Purebred Merino had the finest wool (18.26 µm) and the Merino x Dormer cross the coarsest (26.01 µm). However, all lines still produced wool that could be used in manufacturing clothing, while fleeces showed good uniformity. The two purebred lines had the highest comfort factor (> 98%). The crossbred lines produced a similar quantity of wool as the purebreds, although of poorer quality. All genotypes except Merino x Dormer appear to produce wool that could be processed into garments, although the crossbred wool would only be suitable for outerwear.


Subject(s)
Sheep, Domestic , Wool , Sheep/genetics , Animals , Male , Female , Sheep, Domestic/genetics , Genotype , Reproduction , Phenotype
3.
J Card Fail ; 2023 Oct 30.
Article in English | MEDLINE | ID: mdl-37907150

ABSTRACT

BACKGROUND: Primary graft dysfunction (PGD) is the leading cause of morbidity and mortality early after heart transplantation (HT). The International Consortium on PGD is a multicenter collaboration dedicated to identifying the clinical risk factors for PGD in the contemporary era of HT. The objectives of the current report were (1) to assess the incidence of severe PGD in an international cohort; (2) to evaluate the performance of the most strongly validated PGD risk tool, the RADIAL score, in a contemporary cohort; and (3) to redefine clinical risk factors for severe PGD in the current era of HT. METHODS: This is a retrospective, observational study of consecutive adult HT recipients between 2010 and 2020 in 10 centers in the United States, Canada and Europe. Patients with severe PGD were compared to those without severe PGD (comprising those with no, mild and moderate PGD). The RADIAL score was calculated for each transplant recipient. The discriminatory power of the RADIAL score was evaluated using receiver operating characteristic (ROC) analysis, and its calibration was assessed by plotting the percentage of PGD predicted vs that which was observed. To identify clinical risk factors associated with severe PGD, we performed multivariable mixed-effects logistic regression modeling to account for among-center variability. RESULTS: A total of 2746 patients have been enrolled in the registry to date, including 2015 (73.4%) from North America, and 731 (26.6%) from Europe; 215 participants (7.8%) met the criteria for severe PGD. There was an increase in the incidence of severe PGD over the study period (P value for trend by difference sign test = 0.004). The Kaplan-Meier estimate for 1-year survival was 75.7% (95% CI 69.4-80.9%) in patients with severe PGD as compared to 94.4% (95% CI 93.5-95.2%) in those without severe PGD (log-rank P value < 0.001). The RADIAL score performed poorly in our contemporary cohort and was not associated with severe PGD; it had an AUC of 0.53 (95% CI 0.48-0.58). In the multivariable regression model, acute preoperative dialysis (OR 2.41, 95% CI 1.31-4.43), durable left ventricular assist device support (OR 1.77, 95% CI 1.13-2.77), and total ischemic time (OR 1.20 for each additional hour, 95% CI 1.02-1.41) were associated with an increased risk of severe PGD. CONCLUSIONS: Our consortium has identified an increasing incidence of PGD in the modern transplant era. We identified contemporary risk factors for this early post-transplant complication, which confers a high mortality risk. These results may enable the identification of patients at high risk for developing severe PGD in order to inform peri-transplant donor and recipient management practices.

4.
Trop Anim Health Prod ; 55(5): 325, 2023 Sep 26.
Article in English | MEDLINE | ID: mdl-37749429

ABSTRACT

Producers require an accurate predictive tool that can determine the optimal point of slaughter based on fat depth. The modelling of fat deposition with a simple mathematical model could supply in this need. Dohne Merino and Merino ewes were crossed with Dorper, Dormer and Ile de France rams or rams of their own breeds to create two purebred (Dohne Merino and Merino) and six crossbred groups (Dohne x Dorper, Dohne x Dormer, Dohne x Ile de France, Merino x Dorper, Merino x Dormer and Merino x Ile de France) of offspring. Fat deposition of four lambs of each sex per genotypic group was monitored from 80 to 360 days using ultrasound, and the data subsequently fitted to various equations and evaluated for goodness of fit. A linear fitting of fat depth to age (R2 > 0.77) and live weight (R2 > 0.56) were deemed to provide the best fit. The slope parameters of the equations indicated that ewes deposited fat faster than rams and that Dorper crosses had the highest fat deposition rate. An attempt was also made to model loin muscle growth, but the model fit was judged to be unsatisfactory. The predictive models developed here are deemed suitable for inclusion in feedlot management systems to aid in the production of optimally classified lamb carcasses.


Subject(s)
Sheep, Domestic , Technology , Sheep , Animals , Female , Male , South Africa , Sheep, Domestic/genetics , Ultrasonography , Genotype
5.
Trop Anim Health Prod ; 55(5): 319, 2023 Sep 23.
Article in English | MEDLINE | ID: mdl-37740795

ABSTRACT

Access to simple, accurate feed intake models would facilitate decision-making in feedlots as feed costs are a major part of operational expenditure. This study aimed to develop genotype-specific feed intake models for South African feedlot lambs. Four ram and four ewe lambs each of eight genotypes were raised under ideal growth conditions from weaning until 1 year of age. Feed intake and growth were monitored throughout this period. The intake data were then used to fit various models to predict daily feed intake, intake as percentage of body weight, cumulative intake and feed conversion ratio. No satisfactory univariate models could be found for the prediction of daily or percentage intake, but a good fit was found for cumulative intake data (R2 >0.80, P <0.01). The slope parameters of these linear models show a strong correlation (72%) with feed conversion and can therefore also serve as proxies for feed conversion. A model was also developed that can predict feed conversion ratio with a moderate accuracy (R2 =0.5, P <0.05) at a given body weight. The cumulative intake model was deemed accurate and simple enough for practical use.


Subject(s)
Eating , Female , Animals , Sheep/genetics , Male , Weaning , Body Weight , Genotype , Linear Models
6.
J Trop Pediatr ; 67(1)2021 01 29.
Article in English | MEDLINE | ID: mdl-33693891

ABSTRACT

AIM: The aim of this study is to describe the 30-day mortality, neurodevelopmental outcome and composite outcome (mortality or abnormal neurodevelopmental outcome) of neonates with necrotizing enterocolitis (NEC), requiring neonatal intensive care (NICU) admission, in a resource-restricted environment. METHODS: All neonates admitted to Tygerberg Hospital, NICU, with a presumptive diagnosis of NEC Bell stage IIB or more, over a 5-year period, were included. RESULTS: One hundred and thirty-five neonates were included with a mean gestational age of 29 ± 2.7 weeks and mean birth weight of 1185 g ± 446 g. The 30-day mortality was 52%, neurodevelopment abnormalities occurred in 35% of survivors and adverse composite outcome in 63%. The 30-day mortality and adverse composite outcome risk were increased by small for gestational age, shock, metabolic acidosis, inotrope requirement and first feed >9 days after surgery. CONCLUSION: In resource-restricted environments, mortality and abnormal neurodevelopmental outcome of neonates with NEC, remain high. However, outcomes are comparable with international literature. Neonates with NEC, requiring NICU admission and surgery, require neurodevelopmental follow-up.


Necrotizing enterocolitis remains one of the most common gastrointestinal emergencies in neonates. Neonates admitted to a resource-restricted neonatal intensive care unit with a presumptive diagnosis of advanced NEC were reviewed. We were able to identify risk factors associated with a higher chance of death or poor neurodevelopmental outcomes. Our outcomes are comparable with international literature.


Subject(s)
Enterocolitis, Necrotizing , Infant, Newborn, Diseases , Enterocolitis, Necrotizing/epidemiology , Enterocolitis, Necrotizing/therapy , Hospitals , Humans , Infant , Infant, Newborn , Intensive Care, Neonatal , South Africa/epidemiology
7.
Plant Dis ; 104(1): 168-178, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31697224

ABSTRACT

Apple scab, caused by Venturia inaequalis, is the most common fruit and foliar disease in commercial apple production worldwide. Early in the production season, preventative contact fungicide sprays are essential for protecting highly susceptible continuously unfolding and expanding young leaves. In South Africa, mancozeb is a key contact fungicide used for controlling apple scab early in the season. The current study developed deposition benchmarks indicative of the biological efficacy of mancozeb against apple scab, using a laboratory-based apple seedling model system. The model system employed a yellow fluorescent pigment that is known to be an effective tracer of mancozeb deposition. A concentration range of mancozeb (0.15 to 1 times the registered dosage) and fluorescent pigment concentrations was sprayed onto seedling leaves, which yielded various fluorescent particle coverage (FPC%) levels. Modeling of the FPC% values versus percent disease control yielded different benchmark values when disease quantification was conducted using two different methods. Thermal infrared imaging (TIRI) disease quantification resulted in a benchmark model where 0.40%, 0.79%, and 1.35 FPC% yielded 50, 75, and 90% apple scab control, respectively. These FPC% values were higher than the benchmarks (0.10, 0.20, and 0.34 FPC%, respectively) obtained with quantitative real-time PCR (qPCR) disease quantification. The qPCR benchmark model is recommended as a guideline for evaluating the efficacy of mancozeb sprays on leaves in apple orchards since the TIRI benchmark model underestimated disease control. The TIRI benchmark model yielded 68% disease control at the lowest mancozeb dosage, yet no visible lesion developed at this dosage. Both benchmark models showed that mancozeb yielded high levels of disease control at very low concentrations; for the qPCR benchmark model the FPC% value of the FPC90 (90% control) corresponded to 0.15 times that of the registered mancozeb concentration in South Africa, i.e., 85% lower than the registered dosage.


Subject(s)
Ascomycota , Malus , Maneb , Plant Diseases , Zineb , Ascomycota/drug effects , Benchmarking , Malus/microbiology , Maneb/chemistry , Maneb/pharmacology , Plant Diseases/prevention & control , Plant Leaves/microbiology , South Africa , Zineb/chemistry , Zineb/pharmacology
8.
Public Health ; 136: 152-60, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27178129

ABSTRACT

OBJECTIVES: To examine the association between testing in the 2010 HIV Testing and Counselling (HCT) campaign with HIV risk behaviours and enrolment on ART. STUDY DESIGN: Data for this study were collected as part of a nationally representative cross-sectional household survey conducted in 2012 in South Africa. METHODS: Consenting participants completed a structured questionnaire and provided a dry blood spot specimen which was tested for HIV antibodies and antiretroviral drugs. Multinomial logistic regression was used to examine the association between HIV testing history and explanatory variables of interest. RESULTS: There was no association between testing in the 2010 HCT campaign and condom use at last sex, number of sexual partnerships or HIV knowledge. Individuals who tested in the HCT campaign were more likely to disclose their status (COR 2.6, 95% CI: 1.71-3.8) and those who tested HIV positive in the campaign were more likely to be receiving ART (COR 1.8, 95% CI: 1.1-2.9). Testing in the HCT campaign was associated with having received both pretest and post-test counselling while testing before the campaign was associated with having received HIV results with no counselling (COR 2.1, 95% CI: 1.2-3.8). CONCLUSION: We highlight the success of the 2010 HCT campaign in improving HIV status disclosure and enrolment on ART as well as shortcomings on HIV risk behaviours and HIV knowledge. These may be related to issues of quality assurance in the counselling process. Our results further highlight possible HCT counselling inconsistencies across sectors requiring stronger public-private partnership in the delivery of HCT in South Africa.


Subject(s)
Counseling , HIV Infections/prevention & control , HIV Infections/psychology , Health Promotion , Mass Screening/statistics & numerical data , Patient Acceptance of Health Care/statistics & numerical data , Risk-Taking , Adolescent , Adult , Anti-Retroviral Agents/therapeutic use , Cross-Sectional Studies , Female , HIV Infections/drug therapy , Humans , Male , Middle Aged , South Africa , Surveys and Questionnaires , Young Adult
9.
Bioprocess Biosyst Eng ; 36(9): 1311-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23306531

ABSTRACT

Simultaneous saccharification and fermentation received an increasing level of attention over recent decades, with the primary focus on the development of improved enzyme and organism performance. Little literature is available on the effects of the various fermentation components on the apparent dynamic viscosity of the fermentation broth for use in reactor design and analysis. This work investigates density and settling properties of Avicel PH-101 particles and the effects of base medium composition, yeast concentration and cellulose particles on the apparent dynamic viscosity of the fermentation mixture. Dynamic viscosity measurements were obtained using a rotational viscometer equipped with a DG 26.7 double gap concentric cylinder measuring system. Results indicated that Avicel particles experience a greater drag force compared to similar sized spherical particles and have a measured density of 1,605.7 kg m(-3). The Ostwäld-de Waele formulation was used to describe the dynamic viscosity of the particles due to it shear-thinning nature. Correlation between the predicted particle effects and experimental results deviated with a root mean square error of 8.46 %.


Subject(s)
Cellulose/chemistry , Ethanol/metabolism , Models, Biological , Saccharomyces cerevisiae/growth & development , Viscosity
10.
J Matern Fetal Neonatal Med ; 26(10): 1036-41, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23356686

ABSTRACT

OBJECTIVE: To asses the relation between echogenicity changes in the fetal brain and neurodevelopmental outcome until 6 years of age. METHODS: Fetuses (n = 124) from pregnancies affected by hypertensive disorders (n = 64) or preterm labor (n = 60) at risk for preterm birth (26-34 weeks gestation) were studied. Moderate echogenicity changes (periventricular grade IB, II; intraventricular grade II-III; local basal ganglia/thalami) in the fetal and neonatal brain were related to neurological outcome and Griffiths mental developmental scales quotients at 1, 2 and 6 years. Multiple regression analysis tested the influence of moderate echogenicity changes and perinatal clinical characteristics on composite outcome (death or abnormal neurodevelopment). RESULTS: Moderate echogenicity changes were present in 37/124 (30%) fetuses. Median gestational age and weight at birth were respectively 31 weeks (range 26-43), 1314 g (range 550-4330), mortality was 19%, follow-up loss 10%. Composite outcome was abnormal in 47/124 (38%). Fetal and neonatal moderate intraventricular echodensities were related to cerebral palsy at 6 years (p < 0.04). In the multiple regression analysis only gestational age was related to composite outcome (p = 0.005). CONCLUSIONS: Moderate intraventricular echodensities in the fetal brain related to cerebral palsy at 6 years of age. Gestational age at birth was the main predictor of abnormal composite outcome.


Subject(s)
Brain/abnormalities , Child Development , Adult , Brain/embryology , Cerebral Palsy/diagnostic imaging , Child , Child, Preschool , Echoencephalography , Female , Fetal Membranes, Premature Rupture/diagnostic imaging , Fetal Membranes, Premature Rupture/epidemiology , Follow-Up Studies , Humans , Hypertension, Pregnancy-Induced/diagnostic imaging , Hypertension, Pregnancy-Induced/epidemiology , Infant , Infant, Newborn , Pregnancy , Ultrasonography, Prenatal
11.
Acta Gastroenterol Belg ; 75(4): 454-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23402092

ABSTRACT

Crohn's disease is rare in South African black people and primary sclerosing cholangitis (PSC) is also rare in black patients with IBD, from South Africa. The presence of HLA-B27 is generally associated with seronegative spondylo-arthropathies and correlates with the occurrence of ankylosing spondylitis, recurrent mouth ulcers and uveitis, in patients with IBD. We describe two women with the combination of Crohn's disease, PSC and HLA-B27 from our cohort of the last 5 years of three black patients with Crohn's disease. Crohn's disease, PSC and HLA-B27 respectively, occur rarely in black South Africans and their concurrent presence in two black women suggests a pathogenetic link of HLA-B27 between Crohn's disease and PSC in this population. Female gender might be an additional determinant in this setting.


Subject(s)
Cholagogues and Choleretics/administration & dosage , Cholangitis, Sclerosing , Crohn Disease , Genetic Predisposition to Disease/ethnology , HLA-B27 Antigen/genetics , Immunosuppressive Agents/administration & dosage , Adult , Alkaline Phosphatase/blood , Azathioprine/administration & dosage , Back Pain/etiology , Black People , Cholangiopancreatography, Magnetic Resonance/methods , Cholangitis, Sclerosing/complications , Cholangitis, Sclerosing/diagnosis , Cholangitis, Sclerosing/drug therapy , Cholangitis, Sclerosing/ethnology , Cholangitis, Sclerosing/genetics , Cholangitis, Sclerosing/physiopathology , Colonoscopy/methods , Crohn Disease/complications , Crohn Disease/diagnosis , Crohn Disease/drug therapy , Crohn Disease/ethnology , Crohn Disease/genetics , Crohn Disease/physiopathology , Diarrhea/etiology , Female , Humans , Mercaptopurine/administration & dosage , Methotrexate/administration & dosage , Severity of Illness Index , South Africa/epidemiology , Treatment Outcome , Ursodeoxycholic Acid/administration & dosage , gamma-Glutamyltransferase/blood
12.
Article in English | MEDLINE | ID: mdl-21988139

ABSTRACT

Fumonisins are a group of structurally related mycotoxins produced mainly in maize by Fusarium verticillioides and F. proliferatum. The most abundant naturally occurring analogue is fumonisin B(1) (FB(1)), with lesser amounts of fumonisin B(2) (FB(2)) and fumonisin B(3) (FB(3)) occurring. The C-series fumonisins (FCs) are structurally analogous to the B-series but lack the C-1 methyl group. Good and mouldy subsistence-grown maize samples were collected from the Centane and Bizana districts in the former Transkei region of South Africa. After extraction with methanol/water and clean-up on strong anion exchange solid phase extraction cartridges, FB(1), FB(2), FB(3), FC(1), FC(3) and FC(4) were determined by reversed-phase LC-MS/MS using positive ion electrospray ionisation. FB(1) levels in both good and mouldy maize from Centane (means (±SD) 2.75 ± 2.24 and 23.4 ± 12.5 mg kg(-1), respectively) were higher than the corresponding levels in maize samples from Bizana (means 0.056 ± 0.157 and 3.71 ± 5.01 mg kg(-1), respectively). Similarly, FC(1) levels in both good and mouldy maize from Centane (means 0.107 ± 0.099 and 0.814 ± 0.391 mg kg(-1), respectively) were higher than in Bizana, where FC(1) was detected in only one (0.018 mg kg(-1)) of 19 good maize samples and occurred in mouldy maize with a mean of 0.102 ± 0.135 mg kg(-1). A significant correlation (r=0.982, p<0.01) was observed between FB(1) and FC(1) levels in all samples, with FC(1) levels at 3.3% of the corresponding FB(1) levels. FC(4) levels were similar to FC(1), whereas only low amounts of FC(3) were detected.


Subject(s)
Fumonisins/analysis , Zea mays/chemistry , Chromatography, High Pressure Liquid , Food Contamination/analysis , South Africa , Spectrometry, Mass, Electrospray Ionization , Tandem Mass Spectrometry
13.
Metab Brain Dis ; 21(2-3): 171-9, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16770696

ABSTRACT

There is growing consensus in the literature that oxidation status is increased in Alzheimer's disease (AD), and that antioxidant supplementation as prevention or treatment strategy should be investigated further. In the present study the total antioxidant status (TAS) was found to be highly significantly lower in 22 AD patients (p < 0.0001) than in 22 age- and gender matched non-demented controls. The TAS was also lower than controls in 22 patients with vascular dementia, but not significantly. The increased oxidation status in AD was verified using the benzoate hydroxylation method. The origin of the enhanced oxidation status in AD has not been elucidated. To determine whether a causal effect between stress and oxidative status of serum can be demonstrated, a rat model was used with two different kinds of stressors, swim stress (exercise) and restraint stress (non-exercise stress). Following swim stress the maximum oxidative effect was observed at one hour post stress (p < 0.001). At 24 h the oxidative status had recovered significantly to below control values. Restraint stress, however, showed progressively increased oxidation which attained significance after 24 h (p < 0.005). It is postulated that stress may contribute to the higher oxidation status in AD patients.


Subject(s)
Alzheimer Disease/blood , Antioxidants/metabolism , Stress, Psychological/metabolism , Animals , Benzoic Acid/metabolism , Hydroxylation , Male , Rats , Rats, Sprague-Dawley , Restraint, Physical , Swimming/psychology
14.
Andrologia ; 38(3): 87-91, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16669917

ABSTRACT

The minimum value for each of the five main semen parameters, below which conception rarely occurred or did not occur at all, was calculated in a group of 1884 couples complaining of primary and secondary infertility: 304 conceptions including first as well as consecutive conceptions, occurred. The parameters evaluated were (minimum value calculated in this study between brackets) volume (1.0 ml), sperm count ml(-1) (2.0 million), total sperm count (4.0 million), motility (10%), forward progression (2.0 MacLeod units: scale 1-4) and normal sperm morphology (3%). The pregnancy rate in the group of 308 oligozoospermic men and the minimum value of semen parameters were the cornerstones in determining the prognosis for oligozoospermic patients. A sperm count of >2.0 million ml(-1) was considered relatively adequate for eventual conception judged by the 68 of 308 (22.1%) pregnancies that occurred among oligozoospermic men in this study, provided that the other five semen parameters showed values above the minimum value. In cases where the average sperm count was <2 million ml(-1), the chances for conception became rare, viz five of 308 (1.6%). The total number of pregnancies in the group classified as oligozoospermic was 73 (23.7%). With these pregnancies there was no increase in the rate of foetal wastage and congenital abnormalities. Abortion occurred in 15.09% and ectopic pregnancy in 0.9% among first and consecutive pregnancies. One infant among the 56% boys and 44% girls was born with congenital abnormalities. Most of these infants had a normal birth mass of >2500 g.


Subject(s)
Oligospermia/physiopathology , Pregnancy Outcome , Abortion, Spontaneous/epidemiology , Adult , Congenital Abnormalities/epidemiology , Female , Humans , Male , Middle Aged , Oligospermia/diagnosis , Pregnancy , Pregnancy Rate , Pregnancy, Ectopic/epidemiology , Sex Ratio , Sperm Count
16.
Digestion ; 70(1): 61-9, 2004.
Article in English | MEDLINE | ID: mdl-15297779

ABSTRACT

BACKGROUND/AIM: Gastroesophageal reflux disease (GERD) is a prevalent disease associated with a high symptom burden and a reduced quality of life. This multicenter, randomized, double-blind study compared relief from key GERD symptoms (heartburn, acid eructation, and pain on swallowing) and from other gastrointestinal symptoms (epigastric pain, vomiting, nausea, flatulence, retching, and retrosternal feeling of tightness) and safety profiles of the proton pump inhibitor pantoprazole and the H2 antagonist ranitidine in patients suffering from symptomatic GERD. METHODS: The patients [338 intention-to-treat (ITT) population; 284 per-protocol (PP) population] received 20 mg pantoprazole (once daily in the morning) plus ranitidine placebo (once daily in the evening; ITT n = 167, PP n = 136) or pantoprazole placebo (once daily in the morning) plus 300 mg ranitidine (once daily in the evening; ITT n = 171, PP n = 148) for 28 days. The primary efficacy criterion (ITT and PP populations) was relief from key GERD symptoms (heartburn, acid eructation, and pain on swallowing) after 28 days of treatment. Secondary criteria (PP) included relief from key GERD symptoms on day 14, relief from all gastrointestinal symptoms on days 14 and 28, and relief from key GERD symptoms on days 14 and 28. Safety evaluations included adverse events and laboratory assessments. RESULTS: Significantly more pantoprazole-treated patients were free from key GERD symptoms at day 28 (68.3%, n = 114) as compared with ranitidine-treated patients (43.3%, n = 74; 95% confidence interval for odds ratio 1.84-4.51). Pantoprazole was also significantly more efficacious in controlling all gastrointestinal symptoms of GERD. By day 28, 51.5% (n = 70) of the pantoprazole-treated patients were completely symptom free versus 31.1% (n = 46) of the ranitidine-treated patients (95% confidence interval for odds ratio 1.45-3.83). Both treatments were well tolerated. CONCLUSION: Pantoprazole is significantly superior to ranitidine in the treatment of key and associated gastrointestinal symptoms of GERD and is well tolerated.


Subject(s)
Anti-Ulcer Agents/adverse effects , Anti-Ulcer Agents/therapeutic use , Benzimidazoles/adverse effects , Benzimidazoles/therapeutic use , Gastroesophageal Reflux/drug therapy , Omeprazole/analogs & derivatives , Omeprazole/adverse effects , Omeprazole/therapeutic use , Ranitidine/adverse effects , Ranitidine/therapeutic use , Sulfoxides/adverse effects , Sulfoxides/therapeutic use , 2-Pyridinylmethylsulfinylbenzimidazoles , Administration, Oral , Adult , Aged , Anti-Ulcer Agents/administration & dosage , Benzimidazoles/administration & dosage , Double-Blind Method , Female , Humans , Male , Middle Aged , Odds Ratio , Omeprazole/administration & dosage , Pantoprazole , Placebos , Ranitidine/administration & dosage , Severity of Illness Index , Sulfoxides/administration & dosage , Treatment Outcome
18.
Aesthetic Plast Surg ; 24(3): 202-5, 2000.
Article in English | MEDLINE | ID: mdl-10890948

ABSTRACT

The TRAM flap has become the gold standard in breast reconstruction but suffers from the disadvantages of poor color match, different texture, and impaired sensation compared to the normal breast. This study reports on a two-stage procedure to address these problems. The first stage consists of insertion of a tissue expander and surgical delay of the TRAM flap. The second stage consists of removal of the tissue expander and transposition of a deepithelized TRAM flap into the tissue expanded cavity. (The capsule is excised.) Four cases of breast reconstruction are reported. The advantage of this procedure is that it offers the benefits of tissue expansion, viz., normal color match, texture, and sensation, and in addition, reconstruction is achieved with autologous tissue by a pedicled TRAM flap. The vascularity of the TRAM is enhanced by a surgical delay procedure.


Subject(s)
Mammaplasty/methods , Surgical Flaps , Tissue Expansion , Adult , Breast Neoplasms/surgery , Female , Humans , Mastectomy , Middle Aged
19.
Acta Paediatr ; 89(5): 566-70, 2000 May.
Article in English | MEDLINE | ID: mdl-10852194

ABSTRACT

Umbilical artery Doppler flow velocity waveform studies were performed over a period of 4 y on 242 women with severe pre-eclampsia before 34 wk gestation. Sixty-eight (28%) had absent end-diastolic umbilical artery Doppler flow velocities. One hundred and ninety-three infants survived to hospital discharge and were followed at 6-monthly intervals until 48 mo of age. The mean corrected developmental quotient was 94 +/- 8 at 24 mo of age and 87 +/- 9 at 48 mo. Ninety-two percent of the infants had a developmental quotient of >80 at 24 mo and 72% at 48 mo of age. This decline is thought to be due to the impact of social circumstances. There were no differences between the developmental quotients of the infants with normal and those with absent end-diastolic umbilical artery Doppler flow velocities at either 24 or 48 mo of age. At 24 mo of age, infants with absent end-diastolic umbilical artery Doppler flow velocities scored lower in the Performance subscale test (p = 0.03). The developmental quotients of infants from poorer socioeconomic backgrounds were significantly lower than those living in more privileged circumstances. At 48 mo, 153 (97%) of the children presented with normal gross motor development. Four infants had cerebral palsy. No differences were noted in the motor outcomes between the infants of women with normal umbilical artery waveforms and those with absent end-diastolic umbilical artery Doppler flow velocities.


Subject(s)
Developmental Disabilities/etiology , Pre-Eclampsia/physiopathology , Ultrasonography, Doppler , Umbilical Arteries/diagnostic imaging , Blood Flow Velocity , Child, Preschool , Cognition Disorders/etiology , Female , Gestational Age , Humans , Infant , Intelligence , Neuropsychological Tests , Predictive Value of Tests , Pregnancy
20.
Eur J Gastroenterol Hepatol ; 12(2): 197-202, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10741935

ABSTRACT

BACKGROUND AND AIM: The aim of this study was to compare the efficacy and tolerability of low dose pantoprazole (20 mg) (a gastric proton pump inhibitor) with standard dose ranitidine (300 mg) (a histamine-receptor antagonist), in their ability to relieve symptoms and heal oesophageal lesions associated with gastrooesophageal reflux disease (GORD). METHODS: Patients with endoscopically established mild GORD (stage I, modified Savary-Miller classification) were enrolled into a multicentre, randomized, double-blind, parallel-group comparison study (intention-to-treat population, n = 201; age range, 18-82 years). Patients took either oral pantoprazole 20 mg in the morning (n = 101) or ranitidine 300 mg in the evening (n = 100) once daily for 4 weeks or, if the healing was not complete, 8 weeks. Relief from key symptoms (heartburn, acid regurgitation, pain on swallowing) was assessed after 2, 4, and if applicable, 8 weeks. Healing of lesions was confirmed endoscopically after 4 and, if applicable, 8 weeks. RESULTS: Complete relief from key symptoms was noted after 2 weeks in 70/88 (80%) patients treated with pantoprazole vs 45/89 (51%) patients treated with ranitidine ('per-protocol and key-point available' populations, P < 0.001); the corresponding results after 4 weeks were 77/88 (88%) vs 51/88 (58%) (P < 0.001). Complete healing of lesions after 4 weeks of treatment was seen in 74/88 (84%) vs 49/89 (55%) in the pantoprazole and ranitidine group, respectively (P < 0.001, per-protocol); by week 8 the cumulative healing rates were 84/88 (95%) vs 69/89 (78%) in the pantoprazole and ranitidine group, respectively (P < 0.001). For the intention-to-treat populations, the corresponding values for healing after 4 and 8 weeks were 73% vs 49% (P < 0.001) and 83% vs 69% (P < 0.05), respectively. Both study medications were well tolerated. CONCLUSION: Compared to ranitidine 300 mg, the regimen with pantoprazole 20 mg provides faster relief from symptoms and is significantly more effective in healing of oesophageal lesions in patients with mild reflux-oesophagitis. Thus, the low dose of pantoprazole offers a treatment approach which minimizes drug exposure and costs while retaining high efficacy.


Subject(s)
Benzimidazoles/therapeutic use , Enzyme Inhibitors/therapeutic use , Gastroesophageal Reflux/drug therapy , Histamine H2 Antagonists/therapeutic use , Ranitidine/therapeutic use , Sulfoxides/therapeutic use , 2-Pyridinylmethylsulfinylbenzimidazoles , Adolescent , Adult , Aged , Aged, 80 and over , Double-Blind Method , Esophagitis, Peptic/drug therapy , Esophagitis, Peptic/etiology , Female , Gastroesophageal Reflux/complications , Humans , Male , Middle Aged , Omeprazole/analogs & derivatives , Pantoprazole , Severity of Illness Index , South Africa , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...